Targeting type 2 immune activation beyond atopic dermatitis. Leung DY, Facheris P, Veverka K, Cevikbas F, et al. Ann Allergy Asthma Immunol 2023 Jul 12:S1081-1206(23)00490.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leung DY, Facheris P, Veverka K, Cevikbas F, et al. Targeting type 2 immune activation beyond atopic dermatitis. Ann Allergy Asthma Immunol 2023 Jul 12:S1081-1206(23)00490.
PMID: 37442541